-
Mashup Score: 28
Researchers at Karolinska Institutet, in collaboration with JLP Health and others, have identified how the tick-borne Crimean-Congo hemorrhagic fever virus enters our cells. The results are published …
Source: medicalxpress.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1
Background Crimean-Congo hemorrhagic fever (CCHF) is a widespread disease transmitted to humans and livestock animals through the bite of infected ticks or close contact with infected persons’ blood, organs, or other bodily fluids. The virus is responsible for severe viral hemorrhagic fever outbreaks, with a case fatality rate of up to 40%. Despite having the highest fatality rate of the virus, a…
Source: BioMed CentralCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 3
A recent study on Crimean-Congo Hemorrhagic Fever Virus may pave the way for a new monoclonal antibody treatment in the near future.
Source: ForbesCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0
The discovery of therapeutically relevant monoclonal antibodies could lead to a treatment for the emerging, zoonotic, Crimean Congo Hemorrhagic Fever virus.
Categories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 3Discovery of antibody structure could lead to treatment for Crimean Congo Hemorrhagic Fever virus - 1 year(s) ago
Study provides insights into fighting broad range of pathogen’s viral strains
Source: NewsCategories: General Medicine News, Latest HeadlinesTweet
New study shows how the Crimean-Congo #hemorrhagicFever virus enters our cells @NatureMicrobiol https://t.co/6mcyokcmtv